Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer
about
Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study.The PARP inhibitors, veliparib and olaparib, are effective chemopreventive agents for delaying mammary tumor development in BRCA1-deficient miceSurvival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy.The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.BRCA mutation testing in determining breast cancer therapy.Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry.Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.Risk of Ipsilateral and Contralateral Cancer in BRCA Mutation Carriers with Breast Cancer.Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers.Bilateral breast cancers.Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.A Bayesian Hierarchical Model for Relating Multiple SNPs within Multiple Genes to Disease Risk.Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?A Dietary Intervention to Lower Serum Levels of IGF-I in Mutation Carriers
P2860
Q30418239-A757B2EA-EC9C-4B9F-9710-AE66E66ED7D8Q33874466-B8C9C741-50A4-4C0C-8E9F-E303FA82B063Q34113473-7A3D6334-B4B8-4BE5-90A7-2C6F1230416FQ34481713-5309BED2-CC62-4B2E-95CD-71973908E145Q35006900-F33DD794-E321-4AE7-B0CF-55BABEB60770Q35619225-B6D4441C-7721-4305-99DD-F883D9965660Q35983751-BDCCBF62-1201-415A-98D3-CF45876E52ACQ36210166-594A19DA-A306-49F1-A45A-81C33E5896EFQ37085141-F2BE8348-63AD-453E-A94A-E099F041F49DQ37122297-A8A3C035-86C3-40E8-88FE-88B788DDFB93Q37430003-E11D85EA-3A75-4B9C-BBB8-AED857FC858EQ37609525-143888A0-5A8D-4E41-9C54-A815E50497E7Q37666919-7D207F35-C8A3-42A7-953C-13A7979C63ABQ38184906-202F9A55-F445-42A0-9865-BE61341BE70DQ38190905-5AA9A9EF-6EA1-426F-93B1-6D95F085D013Q41873773-DD4DB4E3-0C5D-4F0F-A090-C6C652EFA837Q43624639-B25CE8E9-A3F0-4254-BA7F-ACD5F916950FQ58764289-90CBC7FC-836E-41FA-84C7-3479E7E3AE46
P2860
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Adjuvant systemic therapy for ...... of contralateral breast cancer
@ast
Adjuvant systemic therapy for ...... of contralateral breast cancer
@en
type
label
Adjuvant systemic therapy for ...... of contralateral breast cancer
@ast
Adjuvant systemic therapy for ...... of contralateral breast cancer
@en
prefLabel
Adjuvant systemic therapy for ...... of contralateral breast cancer
@ast
Adjuvant systemic therapy for ...... of contralateral breast cancer
@en
P2093
P2860
P50
P1476
Adjuvant systemic therapy for ...... of contralateral breast cancer
@en
P2093
Bryan M Langholz
Charles F Lynch
Colin B Begg
Jonine L Bernstein
Kathleen E Malone
Kerryn W Reding
Robert W Haile
Shanyan Xue
P2860
P2888
P304
P356
10.1007/S10549-010-0769-3
P407
P577
2010-02-05T00:00:00Z
P5875
P6179
1009586591